The optimal scenario for the introduction of any new technology is that all reimbursement parameters are anticipated and defined in advance. However, competing priorities within many new technology companies make it difficult for these reimbursement parameters to be addressed on a timely basis. In these cases, Presscott Associates can uniquely assist Life Science companies with the following:

In addition, Presscott Associates' long-standing relationships with many of the private payors offer Life Science companies the unique opportunity to access senior executives on a timely basis for discussions regarding coverage and payment of new technologies.